Delphine Hudry

8PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 11, 2023
Results of a 20 Year Retrospective Analysis of Early-Stage Cervical Cancer: Should 3 cm Be Considered the New Ariadne's Thread in Early Cervical Cancer Treatment?

Benjamin Serouart, Abel Cordoba, Carlos Martinez-Gomez

|Feb 25, 2023
Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study.

Eric Leblanc, Fabrice Narducci, Gwenaël Ferron

|Jan 20, 2023
Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?

Manon Lefebvre, Mathilde Duchatelet, Houssein El Hajj

|Nov 11, 2022
Tumor-Infiltrating Lymphocytes (TILs) in Epithelial Ovarian Cancer: Heterogeneity, Prognostic Impact, and Relationship with Immune Checkpoints.

Delphine Hudry, Solenn Le Guellec, Samuel Meignan

|Aug 15, 2022
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision-a Literature Review.

Delphine Hudry, Stéphanie Bécourt, Giovanni Scambia

|May 11, 2019
Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group.

Pierre Alain Reboux, Henri Azaïs, Charles Henry Canova

Pageof 2

Frequent Collaborators

4 joint publications

Éric Leblanc

3 joint publications

Marie-Cécile Le Deley

3 joint publications

Houssein El Hajj

1 joint publications

Manel Montesinos-Albert